Roivant will discontinue the development of its drug for a rare lung disease after it failed to show treatment benefits in patients in a mid-stage trial. The company's unit, Kinevant Sciences, said on ...
can lead to persistent coughs lasting beyond three days, requiring effective management to relieve symptoms without hindering natural recovery. SEDIFLÙ syrup, a medical device combining natural ...